Bg pattern

VERRUPATCH 3.75 mg CUTANEOUS PATCHES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VERRUPATCH 3.75 mg CUTANEOUS PATCHES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: information for the user

Verrupatch 3.75mg transdermal patches

salicylic acid

Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you.

Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 7 days.

Contents of the leaflet

  1. What is Verrupatch and what is it used for
  2. What you need to know before using Verrupatch
  3. How to use Verrupatch
  4. Possible side effects
  5. Storage of Verrupatch
  6. Package contents and additional information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Verrupatch and what is it used for

Verrupatch is a medicine in the form of transdermal patches and belongs to the group of anti-wart medicines.

It contains salicylic acid as the active ingredient, with anti-wart properties due to its keratolytic activity, which produces softening and subsequent destruction of the stratum corneum, allowing the elimination of warts.

Verrupatch is indicated for the local treatment of common warts, which usually appear on the hands or feet (plantar warts).

2. What you need to know before using Verrupatch

Do not use Verrupatch

  • If you are allergic to salicylic acid or any of the other components of this medicine (listed in section 6).
  • Do not apply to moles, birthmarks, warts with hair, genital warts, warts on the face or mucous membranes.
  • Do not use this product on irritated or wounded skin or on any area that is infected, inflamed, or reddened.
  • Do not use in children under 2 years of age.
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Warnings and precautions

Consult your doctor or pharmacist before starting to use Verrupatch.

Do not ingest. For cutaneous use (exclusively on the skin).

Avoid contact with healthy skin.

Avoid contact with the eyes.

In case of accidental application to the eyes, rinse with plenty of water.

Diabetic or poorly circulated individuals should consult their doctor before using this medicine.

Children

Do not use in children between 2 and 12 years old without medical advice (see Do not use Verrupatch).

Young children may be at greater risk of side effects.

Other medicines and Verrupatch

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.

Do not use this medicine together with other keratolytics (anti-wart medicines) in the same area, as they may enhance its effect.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Do not use Verrupatch during pregnancy, except for short-term treatment of a small wart.

Oral forms (e.g., tablets) of this class of medicine may cause side effects in the fetus. It is unknown if the same risks apply to Verrupatch when used for warts.

A decision should be made whether to discontinue breastfeeding or discontinue treatment, considering the benefit of breastfeeding for the child and the benefit of treatment for the mother.

C

Verrupatch has no or negligible influence on the ability to drive and use machines.

Verrupatch contains propylene glycol (E-1520)

This medicine contains 11.25 mg of propylene glycol in each dose unit (patch).

Propylene glycol may cause skin irritation.

3. How to use Verrupatch

Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

For cutaneous use (on the skin).

The recommended dose is one Verrupatch patch once a day, preferably before bedtime.

Use in children

Do not use in children under 2 years of age.

In children under 12 years of age and over 2 years, do not use without medical advice and avoid prolonged use in children.

Instructions for correct administration

Hand holding an auto-injector pen with the tip applied to the skin of the abdomenHand holding a syringe with a needle inserted into the skin showing the angle of subcutaneous injection

Two hands holding an auto-injector with the thumb pressing the activation button

  1. Before applying the patch, it is recommended to file the surface of the wart with the file included in the package.
  1. Moisten the area to be treated with water.
  1. Apply the patch so that the non-blue part comes into direct contact with the wart. If necessary, cut to fit so that it only covers the wart and does not touch the surrounding tissue.

Hand holding a syringe with a needle inserted into the skin fold at a 90-degree angle

  1. Fix the patch using the adhesive strip provided.

Hand holding a syringe with a needle inserted into the skin showing the angle of subcutaneous injection

Human foot with toes outlined showing the sole and general outline

Hand holding a syringe with a needle inserted into the skin at an inclined angle for subcutaneous injection

Hand holding a syringe with a needle inclined downward ready for intramuscular injectionLeave the patch on for the night (about 8 hours) and remove it in the morning. Repeat this process daily, for a maximum of 12 weeks, until the wart is eliminated. Generally, a noticeable improvement occurs during the first few days, so a complete resolution can be expected after a period of 3 to 6 weeks of treatment.

Consult your doctor or pharmacist if you do not notice an improvement after 1 week, or if the warts are numerous or if an infection or inflammation occurs.

If you use more Verrupatch than you should

Overdose cases are not expected due to the mode of application of this medicine. Excessive use may cause irritation, especially on healthy skin. Use emollients if necessary.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call a medical center or the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount used.

If you forget to use Verrupatch

Do not apply a double dose to make up for forgotten doses. Apply the product again at your usual time

If you stop treatment with Verrupatch

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone may experience them.

Local irritation may occur if the patches come into contact with the healthy skin surrounding the wart. In this case, it is recommended to temporarily suspend treatment until the irritation disappears. When resuming treatment, make sure the patch is properly cut to only come into contact with the wart tissue.

Excessive scaling has been reported in application to open lesions; also, serious allergic reactions.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Verrupatch

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use this medicine after the expiration date shown on the package after CAD. The expiration date is the last day of the month indicated.

Do not use this medicine if you notice visible signs of deterioration in the appearance of the transdermal patches.

Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Verrupatch

  • The active ingredient is salicylic acid. Each patch contains 3.75 mg of salicylic acid.
  • The other ingredients (excipients) are: propylene glycol (E-1520), karaya gum, polyethylene glycol 300 (Macrogol 300), and quaternium-15.

Appearance of the product and package contents

Verrupatch is presented in the form of circular transdermal patches, 6 mm in diameter, beige in color, and covered with a blue polyethylene film that retains moisture, exerting an occlusive effect.

Each package contains 20 patches arranged in two hermetically sealed, moisture-resistant pouches, with 10 patches each.

To fix the patches in the correct position, 20 dermocompatible adhesive strips are included. A file is also provided to remove any remaining material from the surface of the wart.

Marketing authorization holder

Laboratorios Viñas, S.A.

Provenza, 386

08025 - Barcelona

Spain

Manufacturer

Laboratorios Viñas, S.A.

Torrente Vidalet, 29

08012- Barcelona

Spain

Date of the last revision of this leaflet:November 2024

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

Online doctors for VERRUPATCH 3.75 mg CUTANEOUS PATCHES

Discuss questions about VERRUPATCH 3.75 mg CUTANEOUS PATCHES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for VERRUPATCH 3.75 mg CUTANEOUS PATCHES?
VERRUPATCH 3.75 mg CUTANEOUS PATCHES does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures VERRUPATCH 3.75 mg CUTANEOUS PATCHES?
VERRUPATCH 3.75 mg CUTANEOUS PATCHES is manufactured by Laboratorios Vinas S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of VERRUPATCH 3.75 mg CUTANEOUS PATCHES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether VERRUPATCH 3.75 mg CUTANEOUS PATCHES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to VERRUPATCH 3.75 mg CUTANEOUS PATCHES?
Other medicines with the same active substance () include ADTRALZA 150 mg PRE-FILLED SYRINGE SOLUTION FOR INJECTION, ADTRALZA 300 mg Injectable Solution in a Pre-filled Pen, ALITRETINOIN IFC 10 mg SOFT CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media